Addex Therapeutics logo

Addex Therapeutics Share Price (NASDAQ: ADXN)

$8.09

0.19

(2.41%)

Last updated on

Check the interactive Addex Therapeutics Stock chart to analyse performance

Addex Therapeutics Ltd Key Stats

Check Addex Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.9
Open
$8.16
Market Capitalization
$9.2M
Today's Volume
$2.5K
Revenue TTM
$246.2K
EBITDA
$-2.4M
Earnings Per Share (EPS)
$-7.46
Profit Margin
3521.74%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-163.15%

Stock Returns calculator for Addex Therapeutics Stock including INR - Dollar returns

The Addex Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Addex Therapeutics investment value today

Current value as on today

₹79,778

Returns

₹20,222

(-20.22%)

Returns from Addex Therapeutics Stock

₹25,506 (-25.51%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Addex Therapeutics Stock

67%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Addex Therapeutics Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Addex Therapeutics Ltd

  • Name

    Holdings %

  • Citadel Advisors Llc

    1.10%

  • GAMMA Investing LLC

    0.01%

  • Morgan Stanley - Brokerage Accounts

    0.01%

  • Rhumbline Advisers

    0.01%

Analyst Recommendation on Addex Therapeutics Stock

Rating
Trend

Sell

    10%Buy

    20%Hold

    70%Sell

Based on 10 Wall street analysts offering stock ratings for Addex Therapeutics(by analysts ranked 0 to 5 stars)

Addex Therapeutics Share Price Target

What analysts predicted

Upside of 270.83%

Target:

$30.00

Current:

$8.09

Addex Therapeutics share price target is $30.00, a slight Upside of 270.83% compared to current price of $8.09 as per analysts' prediction.

Addex Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, ADXN stock has moved down by -9.5%
  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 234.91K → 1.50K (in $), with an average decrease of 50.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.20M → -1.47M (in $), with an average decrease of 22.2% per quarter
  • ADXN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 97.2%
  • ADXN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 175.3%
  • Price to Sales

    ForADXN every $1 of sales, investors are willing to pay $21.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Addex Therapeutics Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$452.7K
↓ 74.95%
Net Income
$7.9M
↓ 166.84%
Net Profit Margin
1.7K%
↑ 2400.51%

Addex Therapeutics Technicals Summary

Sell

Neutral

Buy

Addex Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Addex Therapeutics Ltd Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Addex Therapeutics Ltd logo
-3.66%
-4.24%
-31.18%
-62.38%
-97.18%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Addex Therapeutics Ltd

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
Organization
Addex Therapeutics
Employees
2
CEO
Mr. Timothy Mark Dyer
Industry
Health Technology

Key Management of Addex Therapeutics Ltd

NameTitle
Mr. Timothy Mark Dyer
Co-Founder, CEO & Director
Dr. Roger G. Mills M.D.
Chief Medical Officer & Director
Mr. Lénaic Teyssédou
Head of Finance
Dr. Mikhail Kalinichev Ph.D.
Head of Translational Science

Important FAQs about investing in ADXN Stock from India :

What is Addex Therapeutics share price today?

Addex Therapeutics share price today is $8.09 as on at the close of the market. Addex Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Addex Therapeutics share?

Addex Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Addex Therapeutics stock price today i.e. is closed at $8.09, lower by 31.67% versus the 52 week high.

How to invest in Addex Therapeutics Stock (ADXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Addex Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Addex Therapeutics Shares that will get you 0.1854 shares as per Addex Therapeutics share price of $8.09 per share as on August 30, 2025 at 1:27 am IST.

What is the minimum amount required to buy Addex Therapeutics Stock (ADXN) from India?

Indian investors can start investing in Addex Therapeutics (ADXN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Addex Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Addex Therapeutics share’s latest price of $8.09 as on August 30, 2025 at 1:27 am IST, you will get 1.2361 shares of Addex Therapeutics. Learn more about fractional shares .

What are the returns that Addex Therapeutics has given to Indian investors in the last 5 years?

Addex Therapeutics stock has given -97.18% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?